Comparison of high‐power short‐duration and low‐power long‐duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta‐analysis

Background High power shorter duration (HPSD) ablation seen to increase efficacy and safety treating of atrial fibrillation (AF); however, comparative data between HPSD and low power longer duration (LPLD) ablation are limited. Hypothesis We thought that HPSD might bring more clinical benefits. The...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cardiology (Mahwah, N.J.) N.J.), 2020-12, Vol.43 (12), p.1631-1640
Hauptverfasser:	Chen, Chao‐feng, Wu, Jing, Jin, Chao‐lun, Liu, Mei‐jun, Xu, Yi‐zhou
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation atrial fibrillation Cardiac arrhythmia Cardiovascular disease Catheters Clinical Investigations Collaboration efficacy Endoscopy Esophagus high‐power short‐duration ablation Injuries low‐power long‐duration ablation Meta-analysis safety Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background High power shorter duration (HPSD) ablation seen to increase efficacy and safety treating of atrial fibrillation (AF); however, comparative data between HPSD and low power longer duration (LPLD) ablation are limited. Hypothesis We thought that HPSD might bring more clinical benefits. The aim of this meta‐analysis was to evaluate the clinical benefits of HPSD in patients with AF. Methods The Medline, PubMed, Embase, and the Cochrane Library databases were searched for studies comparing HPSD and LPLD ablation. Results Ten trials with 2467 patients were included in the analysis. Pooled analyses demonstrated that HPSD showed a benefit of first‐pass pulmonary vein isolation (PVI) (risk ratio [RR]: 1.20; 95% confidence interval [CI]: 1.10‐1.31, P
ISSN:	0160-9289 1932-8737
DOI:	10.1002/clc.23493